126648 |
BMC MUSCULOSKELETAL DISORDERS |
Standards of care in neuromuscular fields |
2013-05-01 |
10.1186/1471-2474-14-s2-o12 |
Straub Volker |
126647 |
THE ONCOLOGIST |
Concise Drug Review: Azacitidine and Decitabine |
2013-05-01 |
10.1634/theoncologist.2012-0465 |
Derissen E. J. B., Beijnen J. H., Schellens J. H. M. |
126646 |
BMC MUSCULOSKELETAL DISORDERS |
Description of the first two cases of Pompe disease in Bulgaria |
2013-05-01 |
10.1186/1471-2474-14-s2-p21 |
Tournev I, Chamova T, Sinigerska I, Guergueltcheva V, Gospodinova M, Ganova P, Stoilov R, Todorova A, Todorov T |
126645 |
BMC MUSCULOSKELETAL DISORDERS |
Rationale for adjuvant measures in musculoskeletal diseases |
2013-05-01 |
10.1186/1471-2474-14-s2-o10 |
Gast Ulf |
126644 |
THE ONCOLOGIST |
Real-World Effectiveness of Systemic Agents Approved for Advanced Non-Small Cell Lung Cancer: A SEER–Medicare Analysis |
2013-05-01 |
10.1634/theoncologist.2012-0480 |
Owonikoko T. K., Ragin C., Chen Z., Kim S., Behera M., Brandes J. C., Saba N. F., Pentz R., Ramalingam S. S., Khuri F. R. |
126643 |
BMC MUSCULOSKELETAL DISORDERS |
Alglucosidase alfa: 5 years of experience in late-onset Pompe disease |
2013-05-01 |
10.1186/1471-2474-14-s2-o9 |
Schoser Benedikt |
126642 |
THE ONCOLOGIST |
FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience |
2013-05-01 |
10.1634/theoncologist.2012-0435 |
Faris J. E., Blaszkowsky L. S., McDermott S., Guimaraes A. R., Szymonifka J., Huynh M. A., Ferrone C. R., Wargo J. A., Allen J. N., Dias L. E., Kwak E. L., Lillemoe K. D., Thayer S. P., Murphy J. E., Zhu A. X., Sahani D. V., Wo J. Y., Clark J. W., Fernandez-del Castillo C., Ryan D. P., Hong T. S. |
126641 |
BMC MUSCULOSKELETAL DISORDERS |
Long term outcome and clinical experience on immune tolerance induction therapies in infantile Pompe disease |
2013-05-01 |
10.1186/1471-2474-14-s2-o8 |
Austin Stephanie, Kishnani Priya |
126640 |
NEURO-ONCOLOGY |
Contents Page |
2013-05-01 |
10.1093/neuonc/nos346 |
|
126639 |
THE ONCOLOGIST |
The Relationship Between Eight GWAS-Identified Single-Nucleotide Polymorphisms and Primary Breast Cancer Outcomes |
2013-05-01 |
10.1634/theoncologist.2012-0419 |
Bayraktar S., Thompson P. A., Yoo S.-Y., Do K.-a., Sahin A. A., Arun B. K., Bondy M. L., Brewster A. M. |